AbbVie hikes full-year earnings guidance as Humira sales top estimates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. CRNX
3. VRTX
4. WMT
5. LMT
6. RXST
7. RIVN
8. SPGI
9. AGIO
10. NCNO

Go back to AbbVie hikes full-year earnings guidance as Humira sales top estimates
AbbVie (NYSE: ABBV) Delayed: 254.76 --0 (-0%)
Previous Close $254.76    52 Week High $68.12 
Open $254.76    52 Week Low $50.71 
Day High $254.76    P/E 55.26 
Day Low $254.76    EPS $4.61 
Volume 7,335